Docteur Laure Ysebrant de Lendonck
0724.952.561 · rovalta.com · 27/09/2026
Docteur Laure Ysebrant de Lendonck
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODocteur Laure Ysebrant de Lendonck is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Uccle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0724.952.561
- Incorporation
- 15/04/2019
- Legal form
- Private limited company
- Registered office
- Avenue Maréchal Ney 53
1180 Uccle · BruxellesSee on map - Contributed capital
- 12 600,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 330
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 167 k € | +25.7% | 132,8 k € | +99.3% | 66,7 k € | +296% | 16,8 k € | -4.7% | 17,7 k € |
| EBITDA | 114,2 k € | +23.5% | 92,5 k € | +133% | 39,7 k € | +3035% | 1,3 k € | -92.8% | 17,7 k € |
| Operating result | 86,1 k € | +32.2% | 65,1 k € | +206% | 21,3 k € | +253% | -13,9 k € | -429% | 4,2 k € |
| Net result | 55,5 k € | +18.1% | 47 k € | +136% | 19,9 k € | +227% | -15,7 k € | -749% | 2,4 k € |
| Balance sheet | |||||||||
| Equity | 12,6 k € | -72.5% | 45,8 k € | +4042% | -1,2 k € | +94.5% | -21,1 k € | -289% | -5,4 k € |
| Total assets | 146,8 k € | +25.1% | 117,4 k € | +2.9% | 114 k € | +47.6% | 77,3 k € | +6.0% | 72,9 k € |
| Cash | 22,5 k € | +9686% | 230,4 € | -99.3% | 35 k € | +869% | 3,6 k € | +71.1% | 2,1 k € |
| Debts | 134,2 k € | +87.6% | 71,5 k € | -37.9% | 115,2 k € | +17.1% | 98,3 k € | +25.8% | 78,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Avenue Maréchal Ney 53 1180 Uccle| Company | CBE no. |
|---|---|
Laure Ysebrant Immobilière● Active | 1042.553.030 |
YES HORSE● Active | 0770.482.975 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/07/2026 | 23/07/2025 | 27/09/2024 | 09/10/2023 | 24/08/2022 | 27/08/2021 |
| General meeting | 30/06/2026 | 27/06/2025 | 23/09/2024 | 09/10/2023 | 29/07/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 23/07/2026 | French | |
| Micro model | 31/12/2024 | 27/06/2025 | 23/07/2025 | French | |
| Micro model | 31/12/2023 | 23/09/2024 | 27/09/2024 | French | |
| Micro model | 31/12/2022 | 09/10/2023 | 09/10/2023 | French | |
| Micro model | 31/12/2021 | 29/07/2022 | 24/08/2022 | French | |
| Micro model | 31/12/2020 | 25/06/2021 | 27/08/2021 | French | |
| Micro model | 31/12/2019 | 26/06/2020 | 30/11/2020 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202555,5 k €↑
- 2024Annual accounts 202447 k €↑
- 2023Annual accounts 202319,9 k €↑
- 2022Annual accounts 2022-15,7 k €↓
- 2021Annual accounts 20212,4 k €↑
- 2021Name changeDr. Laure YSEBRANT de Lendonck Médecine interne
- 2020Annual accounts 2020-18,3 k €↓
- 2019Annual accounts 2019-2,2 k €
- 15/04/2019IncorporationPrivate limited company
- 2019Name changeDocteur Laure Ysebrant de Lendonck